APIM Therapeutics
Dr. Kostas Alevizopoulos brings more than 20 years of corporate expertise in the development and commercialization of therapeutic, diagnostic, medical device and OTC products. His personal track record combines investment, licensing and commercialization experience with significant research & development and regulatory expertise in both the preclinical and clinical space.
This person is not in any offices
APIM Therapeutics
APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).